Literature DB >> 21933596

Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells improves survival of ultra-long random skin flap.

Ji-Chang Wang1, Lin Xia, Xiao-Bin Song, Chun-E Wang, Feng-Cai Wei.   

Abstract

BACKGROUND: Random flap is one kind of the most widely used skin flaps in reconstructive surgery; however, partial necrosis of its distal end remains a significant problem now. The aim of this study was to evaluate the effect of hypoxia preconditioned bone marrow mesenchymal stem cells (HpBMSCs) transplantation on ultra-long random skin flap survival in rats.
METHODS: Normoxic bone marrow mesenchymal stem cells (nBMSCs) were cultured under normoxia (20% O2) and HpBMSCs under hypoxia (1% O2) for 48 hours before transplantation. Thirty Sprague-Dawley rats were randomly divided into control group, nBMSCs group and HpBMSCs group with each consisting of 10 rats. Survival area of ultra-long random skin flap on the dorsal of rats was measured seven days after flap surgery and cell transplantation. Cell survival in vivo, microvessel density and vascular endothelial growth factor (VEGF) were evaluated by histological examination and enzyme-linked immunosorbent assay.
RESULTS: Compared with other two groups, flap survival area in HpBMSCs group was significantly larger (P < 0.05). Microvessel density in HpBMSCs group (36.20 ± 8.19) was higher than that in nBMSCs group (30.01 ± 5.68) and control group (17.60 ± 4.19) (P < 0.05). VEGF in HpBMSCs group ((300.05 ± 50.41) pg/g) was higher than those in nBMSCs group ((240.55 ± 33.64) pg/g) and control group ((191.65 ± 32.58) pg/g) (P < 0.05).
CONCLUSION: HpBMSCs transplantation improves ultra-long random skin flap survival via promoting angiogenesis of more survival cells.

Entities:  

Mesh:

Year:  2011        PMID: 21933596

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

Review 1.  New advances in the mesenchymal stem cells therapy against skin flaps necrosis.

Authors:  Fu-Gui Zhang; Xiu-Fa Tang
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

2.  Coactivity of Mast Cells and Stem Cells on Angiogenesis and Antioxidants' Potentials at Inflammation, Proliferation, and Tissue Remodeling Phases of Wound.

Authors:  Mahshad Mousavi; Ahmad Khanifar; Nazanin Mousavi; Khatereh Anbari; Farzaneh Chehelcheraghi
Journal:  Arch Plast Surg       Date:  2022-05-27

3.  Effects of Apigenin Treatment on Random Skin Flap Survival in Rats.

Authors:  Xinyi Ma; Yuting Lin; Yingying Liu; Wenjie Li; Jibing He; Miaojie Fang; Dingsheng Lin
Journal:  Front Pharmacol       Date:  2021-02-24       Impact factor: 5.810

Review 4.  Preclinical efficacy of stem cell therapy for skin flap: a systematic review and meta-analysis.

Authors:  Yuan Li; Qi-Lin Jiang; Leanne Van der Merwe; Dong-Hao Lou; Cai Lin
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

Review 5.  Hypoxia-based strategies for angiogenic induction: the dawn of a new era for ischemia therapy and tissue regeneration.

Authors:  Ektoras Hadjipanayi; Arndt F Schilling
Journal:  Organogenesis       Date:  2013-08-08       Impact factor: 2.500

6.  Improved viability of random pattern skin flaps with the use of bone marrow mesenchymal-derived stem cells and chicken embryo extract.

Authors:  Farzaneh Chehelcheraghi; Hossein Eimani; Seyed Homayoon Sadraie; Giti Torkaman; Abdollah Amini; Hashem Shemshadi; Hamid Alavi Majd
Journal:  Iran J Basic Med Sci       Date:  2015-08       Impact factor: 2.699

7.  Effects of Acellular Amniotic Membrane Matrix and Bone Marrow-Derived Mesenchymal Stem Cells in Improving Random Skin Flap Survival in Rats.

Authors:  Farzaneh Chehelcheraghi; Hossein Eimani; Seyed Homayoonsadraie; Giti Torkaman; Abdollah Amini; Hamid Alavi Majd; Hashem Shemshadi
Journal:  Iran Red Crescent Med J       Date:  2016-06-01       Impact factor: 0.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.